cas 943122-71-2|| where to buy 2-((4-(piperazin-1-yl)phenyl)amino)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)pyrimidine-4-carboxamide

Nombre del producto:2-((4-(piperazin-1-yl)phenyl)amino)-N-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)pyrimidine-4-carboxamide

IUPAC Name:2-{[4-(piperazin-1-yl)phenyl]amino}-N-{1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl}pyrimidine-4-carboxamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad
CM165641-1g	in stock	ǸŌǸǙ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Notas adicionales

Verification code*

refresh

: Núm. De CAS :943122-71-2; Fórmula molecular:C25H34N6O; Punto de fusión:-; Código de sonrisas:O=C(C1=NC(NC2=CC=C(N3CCNCC3)C=C2)=NC=C1)NC4C(C5(C)C)(C)CCC5C4; Densidad:

: Número de catálogo:CM165641; Peso molecular:434.59; Punto de ebullición:; Nº Mdl:MFCD11977698; Almacenamiento:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.